<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000269426"><TermName>pyroxamide</TermName><TermPronunciation>(py-ROK-suh-mide)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called histone deacetylase inhibitors.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000709963" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;pyroxamide&quot;" language="en" id="_3"/><MediaLink ref="CDR0000709962" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;piroxamida&quot;" language="es" id="_4"/><SpanishTermName>piroxamida</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del c√°ncer. Pertenece al tipo de medicamentos llamados inhibidores de la deacetilasa de histona.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2002-12-21</DateFirstPublished><DateLastModified>2005-03-02</DateLastModified></GlossaryTerm>
